HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HPV vaccination and cervical cancer.

Abstract
Cervical cancer is the third most common cancer in women worldwide and often affects women under 40 years with young families. Vaccination against the human papillomavirus (HPV) is a major advance, since it offers primary prevention against the infectious agent that is the main cause of the disease. Two prophylactic vaccines have shown great promise in clinical trials. One of these (Gardasil(®)) contains all four HPV types, offering protection against genital warts (types 6 and 11) as well as cervical cancer (types 16 and 18). The other (Cervarix(®)) contains types 16 and 18, targeting cervical cancer alone, but also has a degree of cross-protection against types 31 and 45, which could significantly increase the level of protection. Adolescent girls remain the primary target of vaccination programmes, but the issues of vaccinating boys and older women are increasingly debated.
AuthorsAnne Szarewski
JournalCurrent oncology reports (Curr Oncol Rep) Vol. 14 Issue 6 Pg. 559-67 (Dec 2012) ISSN: 1534-6269 [Electronic] United States
PMID22890794 (Publication Type: Journal Article)
Chemical References
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Papillomavirus Vaccines
  • human papillomavirus vaccine, L1 type 16, 18
Topics
  • Adolescent
  • Cross Protection
  • Female
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Humans
  • Meta-Analysis as Topic
  • Papillomaviridae (classification, immunology)
  • Papillomavirus Infections (immunology, prevention & control, virology)
  • Papillomavirus Vaccines (administration & dosage, immunology)
  • Uterine Cervical Neoplasms (immunology, prevention & control, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: